All News
Filter News
Found 809,021 articles
-
Sierra Oncology to Present at Three Upcoming Investor Conferences
3/3/2021
—HC Wainwright Life Sciences Conference beginning at 7:00 am ET on March 9th— —Roth Conference at 10:00 am ET on March 15 th — —Oppenheimer Healthcare Conference at 1:50 pm ET on March 17 th —
-
Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results
3/3/2021
Protagonist Therapeutics, Inc. (Nasdaq: PTGX), today announced it will host a conference call and webcast on Wednesday, March 10 at 4:30 pm ET / 1:30 pm PT to discuss its fourth quarter and full year 2020 financial results. Conference Call and Webcast Information
-
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference
3/3/2021
Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will present a business overview at the H.C. Wainwright Annual Global Life Sciences Conference, taking place March 9-10, 2021. .
-
G1 Therapeutics to Participate in Two Investor Conferences in March
3/3/2021
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company will participate in two investor conferences in March. Jack Bailey, G1’s Chief Executive Officer, will provide a presentation during the HC Wainwright Global Life Sciences Conference; this presentation will be available starting on March 9, 2021 at 7:00 AM ET.
-
Lantern Pharma to Host Fourth Quarter and Fiscal Year End 2020 Operating and Financial Results Conference Call on March 10, 2021 at 4:00 p.m. ET
3/3/2021
Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence ("A.I.") platform to improve cancer drug discovery and development, and identify patients who will benefit from its portfolio of targeted oncology therapeutics, announced today that it will host a conference call
-
HOOKIPA Pharma to Participate in Upcoming H.C. Wainwright Global Life Sciences Conference
3/3/2021
HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA’s management team will participate in the upcoming H.C. Wainwright Global Life Sciences Conference held virtually from March 9-10, 2021:
-
Prelude Therapeutics Announces Participation at Three Upcoming Virtual Investor Conferences
3/3/2021
Prelude Therapeutics Inc. (“Prelude”, “the Company”, “we”, “our”) (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that members of its management team will participate in three upcoming virtual investor conferences: Barclays Global Healthcare Conference Fireside chat at 8:35 a.m. ET on Wednesday, March 10, 2021
-
Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021
3/3/2021
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today upcoming presentations from its HIV clinical development programs that will be featured during the 2021 Conference on Retroviruses and Opportunistic Infections (CROI 2021), taking place virtually from March 6 – 10, 2021.
-
SQZ Biotech to Present at H.C. Wainwright Global Life Sciences Conference
3/3/2021
SQZ Biotechnologies (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that Armon Sharei, PhD, chief executive officer of SQZ™, will present a corporate overview at the upcoming virtual H.C. Wainwright Global Life Sciences Conference. The presentation will be available through the virtual conference portal on Tuesday, March 9, 2021 at 7:00 am EST.
-
Merck to Present at the Barclays Global Healthcare Conference
3/3/2021
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Michael T. Nally, chief marketing officer, is scheduled to participate in the Barclays Global Healthcare Conference on March 9, 2021 at 1:50 p.m. EST.
-
Repligen Corporation to Present at Barclays Global Healthcare Conference
3/3/2021
Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the Barclays Global Healthcare Conference being held March 9-11. Jon Snodgres, Chief Financial Officer, will participate in a fireside chat on Wednesday, March 10, at 1:50 p.m. EST.
-
AMO Pharma to Participate in Myotonic Dystrophy Foundation Meet the DM Drug Developers Program on March 5, 2021
3/3/2021
AMO Pharma Company to present update on REACH-CDM pivotal clinical trial studying use of AMO-02 in treatment of congenital myotonic dystrophy
-
Kineta Presenting at Multiple Investor Conferences in March 2021
3/3/2021
Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology and neuroscience announced today that Kineta will be presenting at multiple virtual investor events in March 2021.
-
Plus Therapeutics to Participate in Upcoming Virtual Conferences
3/3/2021
Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing novel, targeted therapies for rare and difficult to treat cancers, today announced that Marc Hedrick, M.D., President and Chief Executive Officer of Plus Therapeutics, will present at the following upcoming virtual conferences. Event H.C. Wainwright Global Life Sciences Conference Date March 9-10, 2021
-
MiMedx to Participate at Upcoming Investor Conferences
3/3/2021
MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that management will be participating in the following virtual investor conferences: H.C. Wainwright Global Life Sciences Conference Presentation: Wednesday, March 10, 2021 available to view on-demand beginning at 2:00 PM ET
-
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference
3/3/2021
Xenetic Biosciences, Inc. a biopharmaceutical company focused on advancing a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that Jeffrey Eisenberg, Chief Executive Officer of Xenetic will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021.
-
AnteoTech’s AnteoBind™ Technology Supports First-of-its-Kind COVID-19 Home Test
3/3/2021
AnteoTech’s long-term customer Ellume, producer of next-generation digitally enabled diagnostic solutions, has secured a $231.8 million agreement with the U.S. Government to support accelerated manufacture of its COVID-19 home test.
-
Back-end Revenue Cycle Management Market - Increasing Adoption of Back-End Revenue Cycle Management in the Healthcare Organizations
3/3/2021
The healthcare revenue cycle includes multiple independent yet connected segments, starting from registration to claims management, that are separated by front-end and back-end components.
-
Increasing Awareness about New and Improved Treatment Methods is Key for Driving Growth of Chiari Malformation Treatment Market
3/3/2021
The worldwide Chiari malformation treatment market is relied upon to observe huge development in the two or three years.
-
Single Use Centrifuge Systems Market: Rapid Growth in Life Science Industry Expected to drive the market
3/3/2021
Centrifuge is a laboratory equipment used to separate particles/components from solution based on size, shape, density, viscosity of the solution, and rotational speed.